The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
If it wasn’t already, biotech’s pandemic IPO boom is in full swing.
After a week that saw the largest Chinese biotech IPO in history and another $154 million for a company that emerged only last September, four different biotechs raised over $200 million. Each of them upsized their offerings or priced at the top end — or more — of their original range.
Collectively, they raised $926 million, or an average of $231 million per company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
